Technical Analysis for NK - NantKwest, Inc.

Grade Last Price % Change Price Change
grade B 17.25 -3.04% -0.54
NK closed down 3.04 percent on Friday, January 15, 2021, on 88 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical NK trend table...

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gilligan's Island Sell Setup Bearish Swing Setup -3.04%
MACD Bullish Signal Line Cross Bullish -3.04%
New 52 Week Closing High Bullish -3.04%
Pocket Pivot Bullish Swing Setup -3.04%
New 52 Week High Strength -3.04%
Multiple of Ten Bearish Other -3.04%
Wide Bands Range Expansion -3.04%
Older End-of-Day Signals for NK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NantKwest, Inc. Description

NantKwest, Inc., a biotechnology company, develops immunotherapeutic agents for various clinical conditions. It is initiating a Phase II clinical trial for its activated natural killer product candidate for the treatment of virally-induced cancers, such as polyomavirus induced Merkel cell carcinoma, human Papillomavirus, induced cervical cancer, and head and neck cancer, as well as infectious diseases comprising Ebola and other viral, fungal, and bacterial infections. The company also holds right to commercialize a range of genetically modified derivatives that kills cancer and virally infected cells. In addition, it focuses on to initiate a Phase I/II clinical trials for target activated natural killer product candidate for acute myeloid leukemia and bulky hematological cancers. The company was formerly known as Conkwest, Inc. and changed its name to NantKwest, Inc. in July 2015. NantKwest, Inc. was founded in 2002 and is headquartered in Cardiff-by-the-Sea, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Infectious Diseases Acute Myeloid Leukemia Carcinoma Bacterial Infections Infectious Causes Of Cancer Head And Neck Cancer Virus Hematological Cancers Papillomavirus Cervical Cancer Ebola Human Papillomavirus Infection Carcinogenesis Merkel Cell Carcinoma

Is NK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.05
52 Week Low 2.52
Average Volume 2,415,201
200-Day Moving Average 8.77
50-Day Moving Average 11.31
20-Day Moving Average 14.59
10-Day Moving Average 14.80
Average True Range 1.92
ADX 40.04
+DI 35.92
-DI 11.90
Chandelier Exit (Long, 3 ATRs ) 14.29
Chandelier Exit (Short, 3 ATRs ) 15.97
Upper Bollinger Band 18.73
Lower Bollinger Band 10.46
Percent B (%b) 0.82
BandWidth 56.68
MACD Line 1.36
MACD Signal Line 1.19
MACD Histogram 0.1696
Fundamentals Value
Market Cap 1.87 Billion
Num Shares 109 Million
EPS -0.89
Price-to-Earnings (P/E) Ratio -19.32
Price-to-Sales 9386.43
Price-to-Book 6.72
PEG Ratio 2.56
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.64
Resistance 3 (R3) 19.68 18.93 19.24
Resistance 2 (R2) 18.93 18.32 18.91 19.10
Resistance 1 (R1) 18.09 17.95 17.72 18.05 18.97
Pivot Point 17.34 17.34 17.15 17.32 17.34
Support 1 (S1) 16.50 16.73 16.13 16.46 15.53
Support 2 (S2) 15.75 16.36 15.73 15.40
Support 3 (S3) 14.91 15.75 15.26
Support 4 (S4) 14.87